Pro Share Advisors LLC Lucid Diagnostics Inc. Transaction History
Pro Share Advisors LLC
- $46.4 Billion
- Q3 2025
A detailed history of Pro Share Advisors LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 12,151 shares of LUCD stock, worth $13,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,151
Previous 14,194
14.39%
Holding current value
$13,123
Previous $16,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUCD
# of Institutions
84Shares Held
31.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.52MShares$4.89 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA4MShares$4.32 Million0.15% of portfolio
-
Two Seas Capital LP Rye, NY3MShares$3.24 Million0.06% of portfolio
-
Awm Investment Company, Inc. New York, NY2.99MShares$3.23 Million0.37% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT2.96MShares$3.2 Million0.33% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $41.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...